{"id":54533,"date":"2023-03-06T17:07:21","date_gmt":"2023-03-06T16:07:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/"},"modified":"2023-03-06T17:07:21","modified_gmt":"2023-03-06T16:07:21","slug":"epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/","title":{"rendered":"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences"},"content":{"rendered":"<div>\n<p>SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.epic-bio.com%2F&amp;esheet=53356143&amp;newsitemid=20230306005124&amp;lan=en-US&amp;anchor=Epic+Bio&amp;index=1&amp;md5=8f7d80bbb95e8636310a69a914ed404e\" rel=\"nofollow noopener\" shape=\"rect\">Epic Bio<\/a>, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced presentations at two upcoming scientific and medical conferences.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/5\/EpicBioCMYK300dpi.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/21\/EpicBioCMYK300dpi.jpg\"><\/a><\/p>\n<p>\n<b>Keystone Symposia: Chromatin Architecture in Development and Human Health<br \/>\n<br \/><\/b><b>Poster Title: <\/b>Discovery and engineering of hypercompact transcriptional modulators for robust and durable target gene activation<br \/>\n<br \/><b>Date &amp; Time: <\/b>Monday, March 13, 7:30 p.m. PT<br \/>\n<br \/><b>Poster Number:<\/b> 1507 (Session 1)<br \/>\n<br \/><b>Location: <\/b>Fairmont Empress Victoria Conference Center, British Columbia, Canada\n<\/p>\n<p>\n<b>MDA (Muscular Dystrophy Association) Clinical &amp; Scientific Conference<br \/>\n<br \/><\/b><b>Oral Presentation Title: <\/b>EPI-321, a Potential Cure for FSHD<br \/>\n<br \/><b>Date &amp; Time:<\/b> Wednesday, March 22, 10:15 a.m. CT<br \/>\n<br \/><b>Location: <\/b>Hilton Anatole, Dallas, Texas\n<\/p>\n<p>\n<b>About Epic Bio<\/b>\n<\/p>\n<p>\nEpic Bio is a leading epigenome engineering company, leveraging the power of CRISPR without cutting DNA. The company is using its proprietary Gene Expression Modulation System (GEMS) to develop therapies. Through the company\u2019s library of the most compact Cas DNA-binding proteins to work on human cells, the company is developing in vivo therapies with delivery via a single AAV vector. Epic Bio has an initial focus on Facioscapulohumeral Muscular Dystrophy (FSHD) and is conducting additional research to address Antitrypsin Deficiency (A1AD), Heterozygous Familial Hypocholesterolemia (HeFH), as well as other indications. The company is financially backed by Horizons Ventures and other leading investors. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.epic-bio.com&amp;esheet=53356143&amp;newsitemid=20230306005124&amp;lan=en-US&amp;anchor=www.epic-bio.com&amp;index=2&amp;md5=3d2e30bb88bb421c95747a35a62cc512\" rel=\"nofollow noopener\" shape=\"rect\">www.epic-bio.com<\/a> for more information or follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fepicbiotech&amp;esheet=53356143&amp;newsitemid=20230306005124&amp;lan=en-US&amp;anchor=Twitter&amp;index=3&amp;md5=363a61af3615a03dae1d24a52df5f6d7\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fepic-bio%2F&amp;esheet=53356143&amp;newsitemid=20230306005124&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=2c1a9e4731cf68794d7f6b6a850f7b65\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact<\/b><br \/>Shawn M. Cox<br \/>\n<br \/>Epic Bio<br \/>\n<br \/>Manager, Investor Relations, Corporate Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x53;&#104;&#x61;&#119;&#x6e;&#46;&#x63;&#111;&#x78;&#64;&#x65;&#112;&#x69;&#99;&#x2d;&#98;&#x69;&#111;&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x53;&#104;a&#x77;&#110;&#46;&#x63;&#111;x&#x40;&#101;p&#x69;&#99;-&#x62;&#x69;o&#x2e;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Media Contact<\/b><br \/>Lisa Raffensperger<br \/>\n<br \/>Ten Bridge Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#108;i&#x73;&#97;&#64;&#x74;&#101;n&#x62;&#114;i&#x64;&#103;e&#x63;&#111;m&#x6d;&#117;n&#x69;&#99;a&#x74;&#105;o&#x6e;&#115;&#46;&#x63;&#111;m?subject=Epic%20Bio%20Media%20Request\" rel=\"nofollow noopener\" shape=\"rect\">&#108;i&#x73;a&#x40;t&#x65;&#110;&#x62;&#114;&#x69;&#100;g&#x65;c&#x6f;m&#x6d;&#117;&#x6e;&#105;&#x63;&#97;&#x74;&#105;o&#x6e;s&#x2e;c&#x6f;&#109;<\/a><br \/>(617) 903-8783\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced presentations at two upcoming scientific and medical conferences. Keystone Symposia: Chromatin Architecture in Development and Human Health Poster Title: Discovery and engineering of hypercompact transcriptional modulators for robust and durable target gene activation &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54533","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced presentations at two upcoming scientific and medical conferences. Keystone Symposia: Chromatin Architecture in Development and Human Health Poster Title: Discovery and engineering of hypercompact transcriptional modulators for robust and durable target gene activation ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-06T16:07:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/21\/EpicBioCMYK300dpi.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences\",\"datePublished\":\"2023-03-06T16:07:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/\"},\"wordCount\":267,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005124\\\/en\\\/1593825\\\/21\\\/EpicBioCMYK300dpi.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/\",\"name\":\"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005124\\\/en\\\/1593825\\\/21\\\/EpicBioCMYK300dpi.jpg\",\"datePublished\":\"2023-03-06T16:07:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005124\\\/en\\\/1593825\\\/21\\\/EpicBioCMYK300dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005124\\\/en\\\/1593825\\\/21\\\/EpicBioCMYK300dpi.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences - Pharma Trend","og_description":"SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced presentations at two upcoming scientific and medical conferences. Keystone Symposia: Chromatin Architecture in Development and Human Health Poster Title: Discovery and engineering of hypercompact transcriptional modulators for robust and durable target gene activation ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-06T16:07:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/21\/EpicBioCMYK300dpi.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences","datePublished":"2023-03-06T16:07:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/"},"wordCount":267,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/21\/EpicBioCMYK300dpi.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/","url":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/","name":"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/21\/EpicBioCMYK300dpi.jpg","datePublished":"2023-03-06T16:07:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/21\/EpicBioCMYK300dpi.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230306005124\/en\/1593825\/21\/EpicBioCMYK300dpi.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/epic-bio-announces-presentations-at-upcoming-scientific-and-medical-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54533"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54533\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}